Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements

Highlights • 13 clusters of statements had consensus from a multidisciplinary international expert panel on the management of oral mucositis (OM) in head and neck cancer patients (HNCPs). • Before chemo-radiotherapy: general statements, risk factors, assessment tools and preventive hygiene of oral cavity. • During chemo-radiotherapy: statements about recommended, no recommended, suggested and no-suggested practice to manage OM in HNCPs. • Statements about the radiotherapic precautions to be adopted in order toreduce the risk of radioinduced OM in HNCPs.